Global BCG Vaccine for Prevent Covid-19 Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global BCG Vaccine for Prevent Covid-19 market size was valued at US$ million in 2023. With growing demand in downstream market, the BCG Vaccine for Prevent Covid-19 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global BCG Vaccine for Prevent Covid-19 market. BCG Vaccine for Prevent Covid-19 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of BCG Vaccine for Prevent Covid-19. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the BCG Vaccine for Prevent Covid-19 market.
As for March, 26 2020:
Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effects of a novel coronavirus on individuals.The scientists involved in the study hope that BCG vaccination may ease the burden on the health system before a specific vaccine for Covid-19 is available.
1.BCG Clinical Trials for Against Covid-19
Researchers in four countries (the Netherlands, Australia, Germany, and the United Kingdom) will soon begin clinical trials of new coronaviruses using unconventional methods.They will test whether a century-old anti-tuberculosis (TB) vaccine (BCG) can broadly improve the body's immune system, making it better able to fight sars-cov-2 and possibly prevent infection altogether.The study will be administered to people at high risk, including physicians and nurses, and to older adults.
A team at the university of Melbourne in Australia is using exactly the same protocol to carry out the BCG study among healthcare workers.Another team at the university of Exeter in the UK will conduct a similar study on older people.Last week, a team at the Max Planck Institute for Infection Biology in Germany announced that, inspired by Netea's work, they would carry out similar clinical trials in older people and healthcare workers with another anti-tb vaccine in development, VPM1002, a genetically modified BCG vaccine.'The elderly and health care workers are bearing the brunt of the current outbreak, so they would particularly benefit if the VPM1002 vaccine could help.'They said.
2.Introduction of BCG
The BCG vaccine consists of an attenuated (weakened) version of a relative of Mycobacterium tuberculosis, the causative agent of TB. The vaccine is in most countries in the world of children after the birth of the first annual vaccination is used, the BCG vaccine to be both safe and cheap, it can prevent an average of about 60% of TB cases, children vary widely between countries.Vaccines typically produce an immune response against the target pathogen, such as antibodies that bind and neutralize one virus but do not bind to others.But BCG may also enhance the immune system's ability to fight pathogens other than tuberculosis, according to decades of published clinical and observational studies.The researchers concluded that in the first year after vaccination, about 30 percent of all known pathogens, including viruses, could be prevented.A 2014 review by the world health organization concluded that BCG appeared to reduce overall child mortality.
3.BCG can 'Train' Innate Immunity
The innate immune system, composed of white blood cells such as macrophages, natural killer cells and neutrophils, should not have this memory.The team, led by professor Netea, found that BCG could survive for months in human skin, stimulating not only the t-cells and b-cells of mycobacterium memoriae, but also the white blood cells responsible for innate immunity, which can quickly respond to new infections.In a randomized placebo-controlled study published in 2018, the team showed that BCG vaccination prevented the yellow fever virus from being experimentally infected.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on BCG Vaccine for Prevent Covid-19 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the BCG Vaccine for Prevent Covid-19 market. It may include historical data, market segmentation by Type (e.g., 0.5ml Package, 1ml Package), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the BCG Vaccine for Prevent Covid-19 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the BCG Vaccine for Prevent Covid-19 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the BCG Vaccine for Prevent Covid-19 industry. This include advancements in BCG Vaccine for Prevent Covid-19 technology, BCG Vaccine for Prevent Covid-19 new entrants, BCG Vaccine for Prevent Covid-19 new investment, and other innovations that are shaping the future of BCG Vaccine for Prevent Covid-19.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the BCG Vaccine for Prevent Covid-19 market. It includes factors influencing customer ' purchasing decisions, preferences for BCG Vaccine for Prevent Covid-19 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the BCG Vaccine for Prevent Covid-19 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting BCG Vaccine for Prevent Covid-19 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the BCG Vaccine for Prevent Covid-19 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the BCG Vaccine for Prevent Covid-19 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the BCG Vaccine for Prevent Covid-19 market.
Market Segmentation:
BCG Vaccine for Prevent Covid-19 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global BCG Vaccine for Prevent Covid-19 market?
What factors are driving BCG Vaccine for Prevent Covid-19 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccine for Prevent Covid-19 market opportunities vary by end market size?
How does BCG Vaccine for Prevent Covid-19 break out type, application?
According to our LPI (LP Information) latest study, the global BCG Vaccine for Prevent Covid-19 market size was valued at US$ million in 2023. With growing demand in downstream market, the BCG Vaccine for Prevent Covid-19 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global BCG Vaccine for Prevent Covid-19 market. BCG Vaccine for Prevent Covid-19 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of BCG Vaccine for Prevent Covid-19. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the BCG Vaccine for Prevent Covid-19 market.
As for March, 26 2020:
Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effects of a novel coronavirus on individuals.The scientists involved in the study hope that BCG vaccination may ease the burden on the health system before a specific vaccine for Covid-19 is available.
1.BCG Clinical Trials for Against Covid-19
Researchers in four countries (the Netherlands, Australia, Germany, and the United Kingdom) will soon begin clinical trials of new coronaviruses using unconventional methods.They will test whether a century-old anti-tuberculosis (TB) vaccine (BCG) can broadly improve the body's immune system, making it better able to fight sars-cov-2 and possibly prevent infection altogether.The study will be administered to people at high risk, including physicians and nurses, and to older adults.
A team at the university of Melbourne in Australia is using exactly the same protocol to carry out the BCG study among healthcare workers.Another team at the university of Exeter in the UK will conduct a similar study on older people.Last week, a team at the Max Planck Institute for Infection Biology in Germany announced that, inspired by Netea's work, they would carry out similar clinical trials in older people and healthcare workers with another anti-tb vaccine in development, VPM1002, a genetically modified BCG vaccine.'The elderly and health care workers are bearing the brunt of the current outbreak, so they would particularly benefit if the VPM1002 vaccine could help.'They said.
2.Introduction of BCG
The BCG vaccine consists of an attenuated (weakened) version of a relative of Mycobacterium tuberculosis, the causative agent of TB. The vaccine is in most countries in the world of children after the birth of the first annual vaccination is used, the BCG vaccine to be both safe and cheap, it can prevent an average of about 60% of TB cases, children vary widely between countries.Vaccines typically produce an immune response against the target pathogen, such as antibodies that bind and neutralize one virus but do not bind to others.But BCG may also enhance the immune system's ability to fight pathogens other than tuberculosis, according to decades of published clinical and observational studies.The researchers concluded that in the first year after vaccination, about 30 percent of all known pathogens, including viruses, could be prevented.A 2014 review by the world health organization concluded that BCG appeared to reduce overall child mortality.
3.BCG can 'Train' Innate Immunity
The innate immune system, composed of white blood cells such as macrophages, natural killer cells and neutrophils, should not have this memory.The team, led by professor Netea, found that BCG could survive for months in human skin, stimulating not only the t-cells and b-cells of mycobacterium memoriae, but also the white blood cells responsible for innate immunity, which can quickly respond to new infections.In a randomized placebo-controlled study published in 2018, the team showed that BCG vaccination prevented the yellow fever virus from being experimentally infected.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on BCG Vaccine for Prevent Covid-19 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the BCG Vaccine for Prevent Covid-19 market. It may include historical data, market segmentation by Type (e.g., 0.5ml Package, 1ml Package), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the BCG Vaccine for Prevent Covid-19 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the BCG Vaccine for Prevent Covid-19 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the BCG Vaccine for Prevent Covid-19 industry. This include advancements in BCG Vaccine for Prevent Covid-19 technology, BCG Vaccine for Prevent Covid-19 new entrants, BCG Vaccine for Prevent Covid-19 new investment, and other innovations that are shaping the future of BCG Vaccine for Prevent Covid-19.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the BCG Vaccine for Prevent Covid-19 market. It includes factors influencing customer ' purchasing decisions, preferences for BCG Vaccine for Prevent Covid-19 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the BCG Vaccine for Prevent Covid-19 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting BCG Vaccine for Prevent Covid-19 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the BCG Vaccine for Prevent Covid-19 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the BCG Vaccine for Prevent Covid-19 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the BCG Vaccine for Prevent Covid-19 market.
Market Segmentation:
BCG Vaccine for Prevent Covid-19 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- by Dosage
- 0.5ml Package
- 1ml Package
- 2ml Package
- Other
- by Type of Inoculator
- Initial Vaccinate
- Revaccination
- 0-5 Years Old
- 5-18 Years Old
- 18-45 Years Old
- 45-65 Years Old
- ?65 Years Old
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Sanofi Pasteur
- Japan BCG Lab
- China National Biotec
- InterVax
- Serum Institute of India
- GreenSignal
- Statens Serum Institute
- Shanyao Group
- Shanghai Institute of Biological Products
What is the 10-year outlook for the global BCG Vaccine for Prevent Covid-19 market?
What factors are driving BCG Vaccine for Prevent Covid-19 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccine for Prevent Covid-19 market opportunities vary by end market size?
How does BCG Vaccine for Prevent Covid-19 break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for BCG Vaccine for Prevent Covid-19 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for BCG Vaccine for Prevent Covid-19 by Country/Region, 2019, 2023 & 2030
2.2 BCG Vaccine for Prevent Covid-19 Segment by Type
2.2.1 0.5ml Package
2.2.2 1ml Package
2.2.3 2ml Package
2.2.4 Other
2.3 BCG Vaccine for Prevent Covid-19 Sales by Type
2.3.1 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
2.3.2 Global BCG Vaccine for Prevent Covid-19 Revenue and Market Share by Type (2019-2024)
2.3.3 Global BCG Vaccine for Prevent Covid-19 Sale Price by Type (2019-2024)
2.4 BCG Vaccine for Prevent Covid-19 Segment by Application
2.4.1 0-5 Years Old
2.4.2 5-18 Years Old
2.4.3 18-45 Years Old
2.4.4 45-65 Years Old
2.4.5 ?65 Years Old
2.5 BCG Vaccine for Prevent Covid-19 Sales by Application
2.5.1 Global BCG Vaccine for Prevent Covid-19 Sale Market Share by Application (2019-2024)
2.5.2 Global BCG Vaccine for Prevent Covid-19 Revenue and Market Share by Application (2019-2024)
2.5.3 Global BCG Vaccine for Prevent Covid-19 Sale Price by Application (2019-2024)
3 GLOBAL BCG VACCINE FOR PREVENT COVID-19 BY COMPANY
3.1 Global BCG Vaccine for Prevent Covid-19 Breakdown Data by Company
3.1.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales by Company (2019-2024)
3.1.2 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Company (2019-2024)
3.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue by Company (2019-2024)
3.2.1 Global BCG Vaccine for Prevent Covid-19 Revenue by Company (2019-2024)
3.2.2 Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Company (2019-2024)
3.3 Global BCG Vaccine for Prevent Covid-19 Sale Price by Company
3.4 Key Manufacturers BCG Vaccine for Prevent Covid-19 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccine for Prevent Covid-19 Product Location Distribution
3.4.2 Players BCG Vaccine for Prevent Covid-19 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BCG VACCINE FOR PREVENT COVID-19 BY GEOGRAPHIC REGION
4.1 World Historic BCG Vaccine for Prevent Covid-19 Market Size by Geographic Region (2019-2024)
4.1.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic BCG Vaccine for Prevent Covid-19 Market Size by Country/Region (2019-2024)
4.2.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales by Country/Region (2019-2024)
4.2.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue by Country/Region (2019-2024)
4.3 Americas BCG Vaccine for Prevent Covid-19 Sales Growth
4.4 APAC BCG Vaccine for Prevent Covid-19 Sales Growth
4.5 Europe BCG Vaccine for Prevent Covid-19 Sales Growth
4.6 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Growth
5 AMERICAS
5.1 Americas BCG Vaccine for Prevent Covid-19 Sales by Country
5.1.1 Americas BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024)
5.1.2 Americas BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024)
5.2 Americas BCG Vaccine for Prevent Covid-19 Sales by Type
5.3 Americas BCG Vaccine for Prevent Covid-19 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccine for Prevent Covid-19 Sales by Region
6.1.1 APAC BCG Vaccine for Prevent Covid-19 Sales by Region (2019-2024)
6.1.2 APAC BCG Vaccine for Prevent Covid-19 Revenue by Region (2019-2024)
6.2 APAC BCG Vaccine for Prevent Covid-19 Sales by Type
6.3 APAC BCG Vaccine for Prevent Covid-19 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG Vaccine for Prevent Covid-19 by Country
7.1.1 Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024)
7.1.2 Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024)
7.2 Europe BCG Vaccine for Prevent Covid-19 Sales by Type
7.3 Europe BCG Vaccine for Prevent Covid-19 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG Vaccine for Prevent Covid-19 by Country
8.1.1 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024)
8.1.2 Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024)
8.2 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Type
8.3 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccine for Prevent Covid-19
10.3 Manufacturing Process Analysis of BCG Vaccine for Prevent Covid-19
10.4 Industry Chain Structure of BCG Vaccine for Prevent Covid-19
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccine for Prevent Covid-19 Distributors
11.3 BCG Vaccine for Prevent Covid-19 Customer
12 WORLD FORECAST REVIEW FOR BCG VACCINE FOR PREVENT COVID-19 BY GEOGRAPHIC REGION
12.1 Global BCG Vaccine for Prevent Covid-19 Market Size Forecast by Region
12.1.1 Global BCG Vaccine for Prevent Covid-19 Forecast by Region (2025-2030)
12.1.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global BCG Vaccine for Prevent Covid-19 Forecast by Type
12.7 Global BCG Vaccine for Prevent Covid-19 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.1.3 Merck BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.2.3 Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.3.3 Japan BCG Lab BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
13.4.1 China National Biotec Company Information
13.4.2 China National Biotec BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.4.3 China National Biotec BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 China National Biotec Main Business Overview
13.4.5 China National Biotec Latest Developments
13.5 InterVax
13.5.1 InterVax Company Information
13.5.2 InterVax BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.5.3 InterVax BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 InterVax Main Business Overview
13.5.5 InterVax Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.6.3 Serum Institute of India BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 GreenSignal
13.7.1 GreenSignal Company Information
13.7.2 GreenSignal BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.7.3 GreenSignal BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 GreenSignal Main Business Overview
13.7.5 GreenSignal Latest Developments
13.8 Statens Serum Institute
13.8.1 Statens Serum Institute Company Information
13.8.2 Statens Serum Institute BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.8.3 Statens Serum Institute BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Statens Serum Institute Main Business Overview
13.8.5 Statens Serum Institute Latest Developments
13.9 Shanyao Group
13.9.1 Shanyao Group Company Information
13.9.2 Shanyao Group BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.9.3 Shanyao Group BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanyao Group Main Business Overview
13.9.5 Shanyao Group Latest Developments
13.10 Shanghai Institute of Biological Products
13.10.1 Shanghai Institute of Biological Products Company Information
13.10.2 Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.10.3 Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Institute of Biological Products Main Business Overview
13.10.5 Shanghai Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for BCG Vaccine for Prevent Covid-19 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for BCG Vaccine for Prevent Covid-19 by Country/Region, 2019, 2023 & 2030
2.2 BCG Vaccine for Prevent Covid-19 Segment by Type
2.2.1 0.5ml Package
2.2.2 1ml Package
2.2.3 2ml Package
2.2.4 Other
2.3 BCG Vaccine for Prevent Covid-19 Sales by Type
2.3.1 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
2.3.2 Global BCG Vaccine for Prevent Covid-19 Revenue and Market Share by Type (2019-2024)
2.3.3 Global BCG Vaccine for Prevent Covid-19 Sale Price by Type (2019-2024)
2.4 BCG Vaccine for Prevent Covid-19 Segment by Application
2.4.1 0-5 Years Old
2.4.2 5-18 Years Old
2.4.3 18-45 Years Old
2.4.4 45-65 Years Old
2.4.5 ?65 Years Old
2.5 BCG Vaccine for Prevent Covid-19 Sales by Application
2.5.1 Global BCG Vaccine for Prevent Covid-19 Sale Market Share by Application (2019-2024)
2.5.2 Global BCG Vaccine for Prevent Covid-19 Revenue and Market Share by Application (2019-2024)
2.5.3 Global BCG Vaccine for Prevent Covid-19 Sale Price by Application (2019-2024)
3 GLOBAL BCG VACCINE FOR PREVENT COVID-19 BY COMPANY
3.1 Global BCG Vaccine for Prevent Covid-19 Breakdown Data by Company
3.1.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales by Company (2019-2024)
3.1.2 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Company (2019-2024)
3.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue by Company (2019-2024)
3.2.1 Global BCG Vaccine for Prevent Covid-19 Revenue by Company (2019-2024)
3.2.2 Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Company (2019-2024)
3.3 Global BCG Vaccine for Prevent Covid-19 Sale Price by Company
3.4 Key Manufacturers BCG Vaccine for Prevent Covid-19 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccine for Prevent Covid-19 Product Location Distribution
3.4.2 Players BCG Vaccine for Prevent Covid-19 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BCG VACCINE FOR PREVENT COVID-19 BY GEOGRAPHIC REGION
4.1 World Historic BCG Vaccine for Prevent Covid-19 Market Size by Geographic Region (2019-2024)
4.1.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic BCG Vaccine for Prevent Covid-19 Market Size by Country/Region (2019-2024)
4.2.1 Global BCG Vaccine for Prevent Covid-19 Annual Sales by Country/Region (2019-2024)
4.2.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue by Country/Region (2019-2024)
4.3 Americas BCG Vaccine for Prevent Covid-19 Sales Growth
4.4 APAC BCG Vaccine for Prevent Covid-19 Sales Growth
4.5 Europe BCG Vaccine for Prevent Covid-19 Sales Growth
4.6 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Growth
5 AMERICAS
5.1 Americas BCG Vaccine for Prevent Covid-19 Sales by Country
5.1.1 Americas BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024)
5.1.2 Americas BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024)
5.2 Americas BCG Vaccine for Prevent Covid-19 Sales by Type
5.3 Americas BCG Vaccine for Prevent Covid-19 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccine for Prevent Covid-19 Sales by Region
6.1.1 APAC BCG Vaccine for Prevent Covid-19 Sales by Region (2019-2024)
6.1.2 APAC BCG Vaccine for Prevent Covid-19 Revenue by Region (2019-2024)
6.2 APAC BCG Vaccine for Prevent Covid-19 Sales by Type
6.3 APAC BCG Vaccine for Prevent Covid-19 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG Vaccine for Prevent Covid-19 by Country
7.1.1 Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024)
7.1.2 Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024)
7.2 Europe BCG Vaccine for Prevent Covid-19 Sales by Type
7.3 Europe BCG Vaccine for Prevent Covid-19 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG Vaccine for Prevent Covid-19 by Country
8.1.1 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024)
8.1.2 Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024)
8.2 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Type
8.3 Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccine for Prevent Covid-19
10.3 Manufacturing Process Analysis of BCG Vaccine for Prevent Covid-19
10.4 Industry Chain Structure of BCG Vaccine for Prevent Covid-19
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccine for Prevent Covid-19 Distributors
11.3 BCG Vaccine for Prevent Covid-19 Customer
12 WORLD FORECAST REVIEW FOR BCG VACCINE FOR PREVENT COVID-19 BY GEOGRAPHIC REGION
12.1 Global BCG Vaccine for Prevent Covid-19 Market Size Forecast by Region
12.1.1 Global BCG Vaccine for Prevent Covid-19 Forecast by Region (2025-2030)
12.1.2 Global BCG Vaccine for Prevent Covid-19 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global BCG Vaccine for Prevent Covid-19 Forecast by Type
12.7 Global BCG Vaccine for Prevent Covid-19 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.1.3 Merck BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.2.3 Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.3.3 Japan BCG Lab BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
13.4.1 China National Biotec Company Information
13.4.2 China National Biotec BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.4.3 China National Biotec BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 China National Biotec Main Business Overview
13.4.5 China National Biotec Latest Developments
13.5 InterVax
13.5.1 InterVax Company Information
13.5.2 InterVax BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.5.3 InterVax BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 InterVax Main Business Overview
13.5.5 InterVax Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.6.3 Serum Institute of India BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 GreenSignal
13.7.1 GreenSignal Company Information
13.7.2 GreenSignal BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.7.3 GreenSignal BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 GreenSignal Main Business Overview
13.7.5 GreenSignal Latest Developments
13.8 Statens Serum Institute
13.8.1 Statens Serum Institute Company Information
13.8.2 Statens Serum Institute BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.8.3 Statens Serum Institute BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Statens Serum Institute Main Business Overview
13.8.5 Statens Serum Institute Latest Developments
13.9 Shanyao Group
13.9.1 Shanyao Group Company Information
13.9.2 Shanyao Group BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.9.3 Shanyao Group BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanyao Group Main Business Overview
13.9.5 Shanyao Group Latest Developments
13.10 Shanghai Institute of Biological Products
13.10.1 Shanghai Institute of Biological Products Company Information
13.10.2 Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
13.10.3 Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Institute of Biological Products Main Business Overview
13.10.5 Shanghai Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. BCG Vaccine for Prevent Covid-19 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. BCG Vaccine for Prevent Covid-19 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 0.5ml Package
Table 4. Major Players of 1ml Package
Table 5. Major Players of 2ml Package
Table 6. Major Players of Other
Table 7. Global BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 8. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Table 9. Global BCG Vaccine for Prevent Covid-19 Revenue by Type (2019-2024) & ($ million)
Table 10. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2019-2024)
Table 11. Global BCG Vaccine for Prevent Covid-19 Sale Price by Type (2019-2024) & (USD/Dose)
Table 12. Global BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 13. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Table 14. Global BCG Vaccine for Prevent Covid-19 Revenue by Application (2019-2024)
Table 15. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application (2019-2024)
Table 16. Global BCG Vaccine for Prevent Covid-19 Sale Price by Application (2019-2024) & (USD/Dose)
Table 17. Global BCG Vaccine for Prevent Covid-19 Sales by Company (2019-2024) & (K Doses)
Table 18. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Company (2019-2024)
Table 19. Global BCG Vaccine for Prevent Covid-19 Revenue by Company (2019-2024) ($ Millions)
Table 20. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Company (2019-2024)
Table 21. Global BCG Vaccine for Prevent Covid-19 Sale Price by Company (2019-2024) & (USD/Dose)
Table 22. Key Manufacturers BCG Vaccine for Prevent Covid-19 Producing Area Distribution and Sales Area
Table 23. Players BCG Vaccine for Prevent Covid-19 Products Offered
Table 24. BCG Vaccine for Prevent Covid-19 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global BCG Vaccine for Prevent Covid-19 Sales by Geographic Region (2019-2024) & (K Doses)
Table 28. Global BCG Vaccine for Prevent Covid-19 Sales Market Share Geographic Region (2019-2024)
Table 29. Global BCG Vaccine for Prevent Covid-19 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global BCG Vaccine for Prevent Covid-19 Sales by Country/Region (2019-2024) & (K Doses)
Table 32. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Country/Region (2019-2024)
Table 33. Global BCG Vaccine for Prevent Covid-19 Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)
Table 36. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2024)
Table 37. Americas BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2024)
Table 39. Americas BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 40. Americas BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 41. APAC BCG Vaccine for Prevent Covid-19 Sales by Region (2019-2024) & (K Doses)
Table 42. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Region (2019-2024)
Table 43. APAC BCG Vaccine for Prevent Covid-19 Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC BCG Vaccine for Prevent Covid-19 Revenue Market Share by Region (2019-2024)
Table 45. APAC BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 46. APAC BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 47. Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)
Table 48. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2024)
Table 49. Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2024)
Table 51. Europe BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 52. Europe BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 53. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)
Table 54. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 58. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of BCG Vaccine for Prevent Covid-19
Table 60. Key Market Challenges & Risks of BCG Vaccine for Prevent Covid-19
Table 61. Key Industry Trends of BCG Vaccine for Prevent Covid-19
Table 62. BCG Vaccine for Prevent Covid-19 Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. BCG Vaccine for Prevent Covid-19 Distributors List
Table 65. BCG Vaccine for Prevent Covid-19 Customer List
Table 66. Global BCG Vaccine for Prevent Covid-19 Sales Forecast by Region (2025-2030) & (K Doses)
Table 67. Global BCG Vaccine for Prevent Covid-19 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas BCG Vaccine for Prevent Covid-19 Sales Forecast by Country (2025-2030) & (K Doses)
Table 69. Americas BCG Vaccine for Prevent Covid-19 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC BCG Vaccine for Prevent Covid-19 Sales Forecast by Region (2025-2030) & (K Doses)
Table 71. APAC BCG Vaccine for Prevent Covid-19 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe BCG Vaccine for Prevent Covid-19 Sales Forecast by Country (2025-2030) & (K Doses)
Table 73. Europe BCG Vaccine for Prevent Covid-19 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Forecast by Country (2025-2030) & (K Doses)
Table 75. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global BCG Vaccine for Prevent Covid-19 Sales Forecast by Type (2025-2030) & (K Doses)
Table 77. Global BCG Vaccine for Prevent Covid-19 Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global BCG Vaccine for Prevent Covid-19 Sales Forecast by Application (2025-2030) & (K Doses)
Table 79. Global BCG Vaccine for Prevent Covid-19 Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Merck Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 82. Merck BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Sanofi Pasteur Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 87. Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Sanofi Pasteur Main Business
Table 89. Sanofi Pasteur Latest Developments
Table 90. Japan BCG Lab Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 91. Japan BCG Lab BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 92. Japan BCG Lab BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Japan BCG Lab Main Business
Table 94. Japan BCG Lab Latest Developments
Table 95. China National Biotec Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 96. China National Biotec BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 97. China National Biotec BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. China National Biotec Main Business
Table 99. China National Biotec Latest Developments
Table 100. InterVax Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 101. InterVax BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 102. InterVax BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. InterVax Main Business
Table 104. InterVax Latest Developments
Table 105. Serum Institute of India Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 106. Serum Institute of India BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 107. Serum Institute of India BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Serum Institute of India Main Business
Table 109. Serum Institute of India Latest Developments
Table 110. GreenSignal Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 111. GreenSignal BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 112. GreenSignal BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. GreenSignal Main Business
Table 114. GreenSignal Latest Developments
Table 115. Statens Serum Institute Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 116. Statens Serum Institute BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 117. Statens Serum Institute BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Statens Serum Institute Main Business
Table 119. Statens Serum Institute Latest Developments
Table 120. Shanyao Group Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanyao Group BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 122. Shanyao Group BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. Shanyao Group Main Business
Table 124. Shanyao Group Latest Developments
Table 125. Shanghai Institute of Biological Products Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 126. Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 127. Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. Shanghai Institute of Biological Products Main Business
Table 129. Shanghai Institute of Biological Products Latest Developments
.
Table 1. BCG Vaccine for Prevent Covid-19 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. BCG Vaccine for Prevent Covid-19 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 0.5ml Package
Table 4. Major Players of 1ml Package
Table 5. Major Players of 2ml Package
Table 6. Major Players of Other
Table 7. Global BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 8. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Table 9. Global BCG Vaccine for Prevent Covid-19 Revenue by Type (2019-2024) & ($ million)
Table 10. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2019-2024)
Table 11. Global BCG Vaccine for Prevent Covid-19 Sale Price by Type (2019-2024) & (USD/Dose)
Table 12. Global BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 13. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Table 14. Global BCG Vaccine for Prevent Covid-19 Revenue by Application (2019-2024)
Table 15. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application (2019-2024)
Table 16. Global BCG Vaccine for Prevent Covid-19 Sale Price by Application (2019-2024) & (USD/Dose)
Table 17. Global BCG Vaccine for Prevent Covid-19 Sales by Company (2019-2024) & (K Doses)
Table 18. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Company (2019-2024)
Table 19. Global BCG Vaccine for Prevent Covid-19 Revenue by Company (2019-2024) ($ Millions)
Table 20. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Company (2019-2024)
Table 21. Global BCG Vaccine for Prevent Covid-19 Sale Price by Company (2019-2024) & (USD/Dose)
Table 22. Key Manufacturers BCG Vaccine for Prevent Covid-19 Producing Area Distribution and Sales Area
Table 23. Players BCG Vaccine for Prevent Covid-19 Products Offered
Table 24. BCG Vaccine for Prevent Covid-19 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global BCG Vaccine for Prevent Covid-19 Sales by Geographic Region (2019-2024) & (K Doses)
Table 28. Global BCG Vaccine for Prevent Covid-19 Sales Market Share Geographic Region (2019-2024)
Table 29. Global BCG Vaccine for Prevent Covid-19 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global BCG Vaccine for Prevent Covid-19 Sales by Country/Region (2019-2024) & (K Doses)
Table 32. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Country/Region (2019-2024)
Table 33. Global BCG Vaccine for Prevent Covid-19 Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)
Table 36. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2024)
Table 37. Americas BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2024)
Table 39. Americas BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 40. Americas BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 41. APAC BCG Vaccine for Prevent Covid-19 Sales by Region (2019-2024) & (K Doses)
Table 42. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Region (2019-2024)
Table 43. APAC BCG Vaccine for Prevent Covid-19 Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC BCG Vaccine for Prevent Covid-19 Revenue Market Share by Region (2019-2024)
Table 45. APAC BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 46. APAC BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 47. Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)
Table 48. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2024)
Table 49. Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2024)
Table 51. Europe BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 52. Europe BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 53. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)
Table 54. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024) & (K Doses)
Table 58. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of BCG Vaccine for Prevent Covid-19
Table 60. Key Market Challenges & Risks of BCG Vaccine for Prevent Covid-19
Table 61. Key Industry Trends of BCG Vaccine for Prevent Covid-19
Table 62. BCG Vaccine for Prevent Covid-19 Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. BCG Vaccine for Prevent Covid-19 Distributors List
Table 65. BCG Vaccine for Prevent Covid-19 Customer List
Table 66. Global BCG Vaccine for Prevent Covid-19 Sales Forecast by Region (2025-2030) & (K Doses)
Table 67. Global BCG Vaccine for Prevent Covid-19 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas BCG Vaccine for Prevent Covid-19 Sales Forecast by Country (2025-2030) & (K Doses)
Table 69. Americas BCG Vaccine for Prevent Covid-19 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC BCG Vaccine for Prevent Covid-19 Sales Forecast by Region (2025-2030) & (K Doses)
Table 71. APAC BCG Vaccine for Prevent Covid-19 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe BCG Vaccine for Prevent Covid-19 Sales Forecast by Country (2025-2030) & (K Doses)
Table 73. Europe BCG Vaccine for Prevent Covid-19 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Forecast by Country (2025-2030) & (K Doses)
Table 75. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global BCG Vaccine for Prevent Covid-19 Sales Forecast by Type (2025-2030) & (K Doses)
Table 77. Global BCG Vaccine for Prevent Covid-19 Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global BCG Vaccine for Prevent Covid-19 Sales Forecast by Application (2025-2030) & (K Doses)
Table 79. Global BCG Vaccine for Prevent Covid-19 Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Merck Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 82. Merck BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Sanofi Pasteur Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 87. Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Sanofi Pasteur Main Business
Table 89. Sanofi Pasteur Latest Developments
Table 90. Japan BCG Lab Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 91. Japan BCG Lab BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 92. Japan BCG Lab BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Japan BCG Lab Main Business
Table 94. Japan BCG Lab Latest Developments
Table 95. China National Biotec Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 96. China National Biotec BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 97. China National Biotec BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. China National Biotec Main Business
Table 99. China National Biotec Latest Developments
Table 100. InterVax Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 101. InterVax BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 102. InterVax BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. InterVax Main Business
Table 104. InterVax Latest Developments
Table 105. Serum Institute of India Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 106. Serum Institute of India BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 107. Serum Institute of India BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Serum Institute of India Main Business
Table 109. Serum Institute of India Latest Developments
Table 110. GreenSignal Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 111. GreenSignal BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 112. GreenSignal BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. GreenSignal Main Business
Table 114. GreenSignal Latest Developments
Table 115. Statens Serum Institute Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 116. Statens Serum Institute BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 117. Statens Serum Institute BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Statens Serum Institute Main Business
Table 119. Statens Serum Institute Latest Developments
Table 120. Shanyao Group Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 121. Shanyao Group BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 122. Shanyao Group BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. Shanyao Group Main Business
Table 124. Shanyao Group Latest Developments
Table 125. Shanghai Institute of Biological Products Basic Information, BCG Vaccine for Prevent Covid-19 Manufacturing Base, Sales Area and Its Competitors
Table 126. Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Product Portfolios and Specifications
Table 127. Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. Shanghai Institute of Biological Products Main Business
Table 129. Shanghai Institute of Biological Products Latest Developments
LIST OF FIGURES
.
Figure 1. Picture of BCG Vaccine for Prevent Covid-19
Figure 2. BCG Vaccine for Prevent Covid-19 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Vaccine for Prevent Covid-19 Sales Growth Rate 2019-2030 (K Doses)
Figure 7. Global BCG Vaccine for Prevent Covid-19 Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. BCG Vaccine for Prevent Covid-19 Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 0.5ml Package
Figure 10. Product Picture of 1ml Package
Figure 11. Product Picture of 2ml Package
Figure 12. Product Picture of Other
Figure 13. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type in 2023
Figure 14. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2019-2024)
Figure 15. BCG Vaccine for Prevent Covid-19 Consumed in 0-5 Years Old
Figure 16. Global BCG Vaccine for Prevent Covid-19 Market: 0-5 Years Old (2019-2024) & (K Doses)
Figure 17. BCG Vaccine for Prevent Covid-19 Consumed in 5-18 Years Old
Figure 18. Global BCG Vaccine for Prevent Covid-19 Market: 5-18 Years Old (2019-2024) & (K Doses)
Figure 19. BCG Vaccine for Prevent Covid-19 Consumed in 18-45 Years Old
Figure 20. Global BCG Vaccine for Prevent Covid-19 Market: 18-45 Years Old (2019-2024) & (K Doses)
Figure 21. BCG Vaccine for Prevent Covid-19 Consumed in 45-65 Years Old
Figure 22. Global BCG Vaccine for Prevent Covid-19 Market: 45-65 Years Old (2019-2024) & (K Doses)
Figure 23. BCG Vaccine for Prevent Covid-19 Consumed in ?65 Years Old
Figure 24. Global BCG Vaccine for Prevent Covid-19 Market: ?65 Years Old (2019-2024) & (K Doses)
Figure 25. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2023)
Figure 26. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application in 2023
Figure 27. BCG Vaccine for Prevent Covid-19 Sales Market by Company in 2023 (K Doses)
Figure 28. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Company in 2023
Figure 29. BCG Vaccine for Prevent Covid-19 Revenue Market by Company in 2023 ($ Million)
Figure 30. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Company in 2023
Figure 31. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Geographic Region in 2023
Figure 33. Americas BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 34. Americas BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 35. APAC BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 36. APAC BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 37. Europe BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 38. Europe BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 40. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 41. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Country in 2023
Figure 42. Americas BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country in 2023
Figure 43. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 44. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 45. United States BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Region in 2023
Figure 50. APAC BCG Vaccine for Prevent Covid-19 Revenue Market Share by Regions in 2023
Figure 51. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 52. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 53. China BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 57. India BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Country in 2023
Figure 61. Europe BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country in 2023
Figure 62. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 63. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 64. Germany BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 65. France BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Country in 2023
Figure 70. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 73. Egypt BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of BCG Vaccine for Prevent Covid-19 in 2023
Figure 79. Manufacturing Process Analysis of BCG Vaccine for Prevent Covid-19
Figure 80. Industry Chain Structure of BCG Vaccine for Prevent Covid-19
Figure 81. Channels of Distribution
Figure 82. Global BCG Vaccine for Prevent Covid-19 Sales Market Forecast by Region (2025-2030)
Figure 83. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global BCG Vaccine for Prevent Covid-19 Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global BCG Vaccine for Prevent Covid-19 Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share Forecast by Application (2025-2030)
.
Figure 1. Picture of BCG Vaccine for Prevent Covid-19
Figure 2. BCG Vaccine for Prevent Covid-19 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Vaccine for Prevent Covid-19 Sales Growth Rate 2019-2030 (K Doses)
Figure 7. Global BCG Vaccine for Prevent Covid-19 Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. BCG Vaccine for Prevent Covid-19 Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 0.5ml Package
Figure 10. Product Picture of 1ml Package
Figure 11. Product Picture of 2ml Package
Figure 12. Product Picture of Other
Figure 13. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type in 2023
Figure 14. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2019-2024)
Figure 15. BCG Vaccine for Prevent Covid-19 Consumed in 0-5 Years Old
Figure 16. Global BCG Vaccine for Prevent Covid-19 Market: 0-5 Years Old (2019-2024) & (K Doses)
Figure 17. BCG Vaccine for Prevent Covid-19 Consumed in 5-18 Years Old
Figure 18. Global BCG Vaccine for Prevent Covid-19 Market: 5-18 Years Old (2019-2024) & (K Doses)
Figure 19. BCG Vaccine for Prevent Covid-19 Consumed in 18-45 Years Old
Figure 20. Global BCG Vaccine for Prevent Covid-19 Market: 18-45 Years Old (2019-2024) & (K Doses)
Figure 21. BCG Vaccine for Prevent Covid-19 Consumed in 45-65 Years Old
Figure 22. Global BCG Vaccine for Prevent Covid-19 Market: 45-65 Years Old (2019-2024) & (K Doses)
Figure 23. BCG Vaccine for Prevent Covid-19 Consumed in ?65 Years Old
Figure 24. Global BCG Vaccine for Prevent Covid-19 Market: ?65 Years Old (2019-2024) & (K Doses)
Figure 25. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2023)
Figure 26. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application in 2023
Figure 27. BCG Vaccine for Prevent Covid-19 Sales Market by Company in 2023 (K Doses)
Figure 28. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Company in 2023
Figure 29. BCG Vaccine for Prevent Covid-19 Revenue Market by Company in 2023 ($ Million)
Figure 30. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Company in 2023
Figure 31. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Geographic Region in 2023
Figure 33. Americas BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 34. Americas BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 35. APAC BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 36. APAC BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 37. Europe BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 38. Europe BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales 2019-2024 (K Doses)
Figure 40. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue 2019-2024 ($ Millions)
Figure 41. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Country in 2023
Figure 42. Americas BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country in 2023
Figure 43. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 44. Americas BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 45. United States BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Region in 2023
Figure 50. APAC BCG Vaccine for Prevent Covid-19 Revenue Market Share by Regions in 2023
Figure 51. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 52. APAC BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 53. China BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 57. India BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Country in 2023
Figure 61. Europe BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country in 2023
Figure 62. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 63. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 64. Germany BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 65. France BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Country in 2023
Figure 70. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)
Figure 73. Egypt BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country BCG Vaccine for Prevent Covid-19 Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of BCG Vaccine for Prevent Covid-19 in 2023
Figure 79. Manufacturing Process Analysis of BCG Vaccine for Prevent Covid-19
Figure 80. Industry Chain Structure of BCG Vaccine for Prevent Covid-19
Figure 81. Channels of Distribution
Figure 82. Global BCG Vaccine for Prevent Covid-19 Sales Market Forecast by Region (2025-2030)
Figure 83. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global BCG Vaccine for Prevent Covid-19 Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global BCG Vaccine for Prevent Covid-19 Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Soft Contact Lens Market Growth 2024-2030
US$ 3,660.00
August 2024
130 pages
Global Inosine Pranobex Market Growth 2025-2031
US$ 3,660.00
May 2025
107 pages
Global Breast Lesion Localization Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
99 pages
Global Capnography Sampling Line Market Growth 2023-2029
US$ 3,660.00
March 2023
92 pages
Global Life Science Instrumentation Market Growth 2024-2030
US$ 3,660.00
September 2024
137 pages
